4.8 Article

Diabetes mellitus, fasting blood glucose concentration, and risk of vascular disease: a collaborative meta-analysis of 102 prospective studies

期刊

LANCET
卷 375, 期 9733, 页码 2215-2222

出版社

ELSEVIER SCIENCE INC
DOI: 10.1016/s0140-6736(10)60484-9

关键词

-

资金

  1. British Heart Foundation [RG/08/014]
  2. UK Medical Research Council
  3. Pfizer
  4. BUPA Foundation
  5. Denka
  6. diaDexus
  7. European Union
  8. Evelyn Trust
  9. Fogarty International Centre
  10. GlaxoSmithKline
  11. Merck Sharp
  12. Dohme
  13. National Heart, Lung and Blood Institute
  14. National Institute of Neurological Disorders and Stroke
  15. Novartis
  16. Roche
  17. Wellcome Trust
  18. UK Biobank
  19. Dorothy Hodgkin Postgraduate Award
  20. Gates Cambridge Trust
  21. Overseas Research Studentship Award
  22. Addendrookes Charitable Trust
  23. ERFC
  24. ESRC [ES/G007438/1] Funding Source: UKRI
  25. MRC [MC_U105260558, G0701619, MC_U137686857, MC_U105260792, G0600705, G0902037] Funding Source: UKRI
  26. British Heart Foundation [RG/08/014/24067, RG/08/013/25942, RG/07/008/23674] Funding Source: researchfish
  27. Economic and Social Research Council [ES/G007438/1] Funding Source: researchfish
  28. Medical Research Council [G0902037, G0401527, G19/35, G0100222, MC_U105260558, MC_U105260792, G0701619, G0600705, MC_U137686857, G8802774] Funding Source: researchfish
  29. NATIONAL CENTER FOR RESEARCH RESOURCES [UL1RR029882] Funding Source: NIH RePORTER
  30. NATIONAL INSTITUTE ON AGING [R03AG021162] Funding Source: NIH RePORTER

向作者/读者索取更多资源

Background Uncertainties persist about the magnitude of associations of diabetes mellitus and fasting glucose concentration with risk of coronary heart disease and major stroke subtypes. We aimed to quantify these associations for a wide range of circumstances. Methods We undertook a meta-analysis of individual records of diabetes, fasting blood glucose concentration, and other risk factors in people without initial vascular disease from studies in the Emerging Risk Factors Collaboration. We combined within-study regressions that were adjusted for age, sex, smoking, systolic blood pressure, and body-mass index to calculate hazard ratios (HRs) for vascular disease. Findings Analyses included data for 698 782 people (52765 non-fatal or fatal vascular outcomes; 8.49 million person-years at risk) from 102 prospective studies. Adjusted HRs with diabetes were: 2.00 (95% CI 1.83-2.19) for coronary heart disease; 2.27 (1.95-2.65) for ischaemic stroke; 1.56 (1.19-2.05) for haemorrhagic stroke; 1.84 (1.59-2.13) for unclassified stroke; and 1.73 (1.51-1.98) for the aggregate of other vascular deaths. HRs did not change appreciably after further adjustment for lipid, inflammatory, or renal markers. HRs for coronary heart disease were higher in women than in men, at 40-59 years than at 70 years and older, and with fatal than with non-fatal disease. At an adult population-wide prevalence of 10%, diabetes was estimated to account for 11% (10-12%) of vascular deaths. Fasting blood glucose concentration was non-linearly related to vascular risk, with no significant associations between 3.90 mmol/L and 5.59 mmol/L. Compared with fasting blood glucose concentrations of 3.90-5.59 mmol/L, HRs for coronary heart disease were: 1.07 (0.97-1.18) for lower than 3.90 mmol/L; 1.11 (1.04-1.18) for 5.60-6-09 mmol/L; and 1.17 (1.08-1.26) for 6.10-6.99 mmol/L. In people without a history of diabetes, information about fasting blood glucose concentration or impaired fasting glucose status did not significantly improve metrics of vascular disease prediction when added to information about several conventional risk factors. Interpretation Diabetes confers about a two-fold excess risk for a wide range of vascular diseases, independently from other conventional risk factors. In people without diabetes, fasting blood glucose concentration is modestly and nonlinearly associated with risk of vascular disease.

作者

我是这篇论文的作者
点击您的名字以认领此论文并将其添加到您的个人资料中。

评论

主要评分

4.8
评分不足

次要评分

新颖性
-
重要性
-
科学严谨性
-
评价这篇论文

推荐

暂无数据
暂无数据